A Phase 1 study of JNJ-95437446 in participants with advanced-stage solid tumors
95437446LUC1001
Phase 1 other active
Quick answer
A Phase 1 study of JNJ-95437446 in participants with advanced-stage solid tumors for Locally advanced, metastatic NSCLC, CRC, or HNSCC that has recurred or progressed after prior stand of care therapy is a Phase 1 program (other) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen-Cilag International N.V.
- Indication
- Locally advanced, metastatic NSCLC, CRC, or HNSCC that has recurred or progressed after prior stand of care therapy
- Phase
- Phase 1
- Modality
- other
- Status
- active